Heparinom indukovana trombocitopenija tipa II (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Heparinom indukovana trombocitopenija tipa II" in Serbian language version.

refsWebsite
Global rank Serbian rank
4th place
8th place
2nd place
4th place

doi.org

  • Kilickiran Avci B, Oto A, Ozcebe O. Thrombocytopenia associated with antithrombotic therapy in patients with cardiovascular diseases: diagnosis and treatment. Kilickiran Avci, B.; Oto, A.; Ozcebe, O. (2008). „Thrombocytopenia associated with antithrombotic therapy in patients with cardiovascular diseases: Diagnosis and treatment”. Am J Cardiovasc Drugs. 8 (5): 327—39. PMID 18828644. doi:10.2165/00129784-200808050-00005. .
  • Warkentin TE, Greinacher A. (2004). „Heparin-induced thrombocytopenia: recognition, treatment, and prevention. The Seventh ACCP Confference on Antithrombotic Ant Thrombolytic Therapy”. Chest. 126 (3): 311S—37S. PMID 15383477. doi:10.1378/chest.126.3_suppl.311S. 
  • Warkentin TE, Greinacher A (2004). „Heparin-induced thrombocytopenia: recognition, treatment, and prevention. The Seventh ACCP Confference on Antithrombotic Ant Thrombolytic Therapy”. Chest. 126 (3): 311S—37S. PMID 15383477. doi:10.1378/chest.126.3_suppl.311S. 
  • Das P, Ziada K, Steinhubl SR, Moliterno DJ, Hamdalla H, Jozic J, et al. Heparin-induced thrombocytopenia and cardiovascular diseases. Das, Pranab; Ziada, Khaled; Steinhubl, Steven R.; Moliterno, David J.; Hamdalla, Hussam; Jozic, Joseph; Mukherjee, Debabrata (2006). „Heparin-induced thrombocytopenia and cardiovascular diseases”. Am Heart J. 152 (1): 19—26. PMID 16824828. doi:10.1016/j.ahj.2005.10.005. 
  • Hach-Wunderle V, Kainer K, Krug B, Müller-Berghaus G, Pötzsch B (1994). „Heparin-associated thrombosis despite normal platelet counts”. Lancet. 344 (8920): 469—70. PMID 7914575. doi:10.1016/S0140-6736(94)91797-3. 
  • Cuker A. Heparin-induced thrombocytopenia: present and future. Cuker, Adam (2011). „Heparin-induced thrombocytopenia: Present and future”. J Thromb Thrombolysis. 31 (3): 353—66. PMID 21327506. doi:10.1007/s11239-011-0569-6. .
  • Cuker A. Recent advances in heparin-induced thrombocytopenia. Cuker, A. (2011). „Recent advances in heparin-induced thrombocytopenia”. Curr Opin Hematol. 18 (5): 315—22. PMID 21730833. doi:10.1097/MOH.0b013e3283497ef2. . .
  • Cuker A, Cines DB. How J treat heparin-induced thrombocytopenia. Cuker, A.; Cines, D. B. (2012). „How I treat heparin-induced thrombocytopenia”. Blood. 119 (10): 2209—18. PMID 22246036. doi:10.1182/blood-2011-11-376293. .

nih.gov

ncbi.nlm.nih.gov

  • Kilickiran Avci B, Oto A, Ozcebe O. Thrombocytopenia associated with antithrombotic therapy in patients with cardiovascular diseases: diagnosis and treatment. Kilickiran Avci, B.; Oto, A.; Ozcebe, O. (2008). „Thrombocytopenia associated with antithrombotic therapy in patients with cardiovascular diseases: Diagnosis and treatment”. Am J Cardiovasc Drugs. 8 (5): 327—39. PMID 18828644. doi:10.2165/00129784-200808050-00005. .
  • Warkentin TE, Greinacher A. (2004). „Heparin-induced thrombocytopenia: recognition, treatment, and prevention. The Seventh ACCP Confference on Antithrombotic Ant Thrombolytic Therapy”. Chest. 126 (3): 311S—37S. PMID 15383477. doi:10.1378/chest.126.3_suppl.311S. 
  • Warkentin TE, Greinacher A (2004). „Heparin-induced thrombocytopenia: recognition, treatment, and prevention. The Seventh ACCP Confference on Antithrombotic Ant Thrombolytic Therapy”. Chest. 126 (3): 311S—37S. PMID 15383477. doi:10.1378/chest.126.3_suppl.311S. 
  • Das P, Ziada K, Steinhubl SR, Moliterno DJ, Hamdalla H, Jozic J, et al. Heparin-induced thrombocytopenia and cardiovascular diseases. Das, Pranab; Ziada, Khaled; Steinhubl, Steven R.; Moliterno, David J.; Hamdalla, Hussam; Jozic, Joseph; Mukherjee, Debabrata (2006). „Heparin-induced thrombocytopenia and cardiovascular diseases”. Am Heart J. 152 (1): 19—26. PMID 16824828. doi:10.1016/j.ahj.2005.10.005. 
  • Hach-Wunderle V, Kainer K, Krug B, Müller-Berghaus G, Pötzsch B (1994). „Heparin-associated thrombosis despite normal platelet counts”. Lancet. 344 (8920): 469—70. PMID 7914575. doi:10.1016/S0140-6736(94)91797-3. 
  • Cuker A. Heparin-induced thrombocytopenia: present and future. Cuker, Adam (2011). „Heparin-induced thrombocytopenia: Present and future”. J Thromb Thrombolysis. 31 (3): 353—66. PMID 21327506. doi:10.1007/s11239-011-0569-6. .
  • Cuker A. Recent advances in heparin-induced thrombocytopenia. Cuker, A. (2011). „Recent advances in heparin-induced thrombocytopenia”. Curr Opin Hematol. 18 (5): 315—22. PMID 21730833. doi:10.1097/MOH.0b013e3283497ef2. . .
  • Cuker A, Cines DB. How J treat heparin-induced thrombocytopenia. Cuker, A.; Cines, D. B. (2012). „How I treat heparin-induced thrombocytopenia”. Blood. 119 (10): 2209—18. PMID 22246036. doi:10.1182/blood-2011-11-376293. .